As Seen In
Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT)
7 years ago
Apr 06, 2017 
To read the full study as it appears on ClinicalTrials.gov, click here. Source: Clinical Trials. gov (4/7/17)
by Type
- Press Release (166)
- Product - RCI-02 (3)
- Events (27)
- As Seen In (90)
by Topic
- Press Release (11)
- Financing (8)
- Partnerships (48)
- RCI-02 (6)
- Skin (45)
- Hair (69)
- RCS-01 (2)
- RCT-01 (1)
- Tendon (52)
- RCH-01 (2)
- Media (91)
- Events (1)
by month
- April 2024 (1)
- March 2024 (1)
- October 2023 (1)
- September 2023 (1)
- August 2023 (3)
- March 2023 (1)
- November 2022 (1)
- August 2022 (2)
- July 2022 (2)
- May 2022 (1)
DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.
THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.